Streamlined E-Discovery: Navigating Pharma IP Disputes Efficiently

In the high-stakes realm of pharmaceutical intellectual property litigation, developing effective e-discovery and digital investigation workflows is crucial. These processes are key to crafting strategic arguments, establishing robust cases, and demonstrating that market entry requirements have been sufficiently met. According to Jerry Lay at FTI Consulting, the complexities of patent disputes between major pharmaceutical companies and generics manufacturers have persisted for decades, often leading to costly and time-consuming litigation. These legal battles can also delay the availability of generic drugs in the market, highlighting the importance of streamlined digital investigation methods in resolving such disputes efficiently.